Company intelligence / Profile preview

Medasense

Ownership: Private
Development stage: Commercial

Overview

Medasense has developed a noninvasive sensor and AI technology platform for objective pain assessment. Its flagship product, the PMD‑200™ with NOL® Index, enables clinicians to personalize intraoperative and critical care pain management. Clinical studies have shown that use of the system can reduce intraoperative opioid use and postoperative pain by up to three days after surgery. The technology has been included in critical care guidelines and demonstrated improved patient outcomes with reduced costs.[1][2][3]

Therapeutic areas: OtherNeurology
Modalities: DeviceAI-based monitoring platform (non-pharmacological therapy)Non-pharmacological therapy (monitoring/diagnostics)
Industry: Physiological Monitoring

Drug pipeline

2 assets

PMD-200

Commercial

Indications: Pain monitoring, Nociception monitoring

1 more asset in the full pipeline.

Request access →

Partnerships

Nihon Kohden (exclusive distribution of PMD‑200 in Japan)[1][2]Panakeia LLC (distribution to US government institutions)[2]

Beyond the preview

Go deeper on Medasense.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Medasense.

Explore the full profile